News
FDA panel considers contraindications, removal guidelines for Essure
The FDA advisory panel did not make any formal recommendations on Essure, but some called for the creation of a prospective patient registry.
Rep. Mike Fitzpatrick (R-Pa.), who has been critical of Essure, said that the FDA’s actions are inadequate and said he will push for congressional action, including blocking government agencies from purchasing the device and revoking the FDA’s approval of Essure.